BW284C51: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{Chem-stub}} | {{Chem-stub}} | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
<gallery> | |||
File:BW284C51.svg|BW284C51 | |||
</gallery> | |||
Latest revision as of 00:01, 25 February 2025
BW284C51 is a chemical compound that is known for its role as an acetylcholinesterase inhibitor. It is often used in scientific research to study the effects of acetylcholinesterase inhibition.
Chemical Structure[edit]
BW284C51 is a quinuclidine derivative. Its chemical structure includes a quinuclidine ring, which is a type of bicyclic amine. The quinuclidine ring is attached to a benzene ring via a carbonyl group. The benzene ring is substituted with a chlorine atom and a fluorine atom.
Mechanism of Action[edit]
As an acetylcholinesterase inhibitor, BW284C51 works by blocking the action of the enzyme acetylcholinesterase. This enzyme is responsible for breaking down acetylcholine, a neurotransmitter that is involved in many functions in the body, including muscle movement and memory. By inhibiting acetylcholinesterase, BW284C51 increases the amount of acetylcholine available in the body.
Uses in Research[edit]
BW284C51 is often used in research to study the effects of acetylcholinesterase inhibition. For example, it can be used to investigate the role of acetylcholine in memory and learning, or to study the effects of acetylcholinesterase inhibitors in conditions such as Alzheimer's disease and myasthenia gravis.
Safety and Toxicity[edit]
Like other acetylcholinesterase inhibitors, BW284C51 can have toxic effects if used inappropriately. These can include muscle weakness, bradycardia, and respiratory depression. Therefore, it should be handled with care in a research setting.
See Also[edit]
-
BW284C51

